Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis

por Nash, Peter, Vanhoof, Johan, Hall, Stephen, Arulmani, Udayasankar, Tarzynski-Potempa, Rita, Unnebrink, Kristina, Payne, Andrew N., Cividino, Alfred
Publicado 2016